A detailed history of Pura Vida Investments, LLC transactions in Repligen Corp stock. As of the latest transaction made, Pura Vida Investments, LLC holds 11,225 shares of RGEN stock, worth $1.35 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares
11,225
Holding current value
$1.35 Million
% of portfolio
1.47%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $1.92 Million - $2.34 Million
11,225 New
11,225 $2.06 Million
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $1.8 Million - $2.29 Million
13,000 New
13,000 $2.07 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $2.34 Million - $3.01 Million
15,200 New
15,200 $2.56 Million
Q1 2021

May 12, 2021

SELL
$180.37 - $226.26 $4.51 Million - $5.66 Million
-25,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $3.7 Million - $5.16 Million
25,000 New
25,000 $4.79 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.66B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.